• Something wrong with this record ?

Venoarterial Extracorporeal Membrane Oxygenation for Postcardiotomy Shock-Analysis of the Extracorporeal Life Support Organization Registry

M. Kowalewski, K. Zieliński, D. Brodie, G. MacLaren, G. Whitman, GM. Raffa, U. Boeken, K. Shekar, YS. Chen, C. Bermudez, D. D'Alessandro, X. Hou, J. Haft, J. Belohlavek, I. Dziembowska, P. Suwalski, P. Alexander, RP. Barbaro, M. Gaudino, M. Di...

. 2021 ; 49 (7) : 1107-1117. [pub] 20210701

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
K12 HL138039 NHLBI NIH HHS - United States

OBJECTIVES: Refractory postcardiotomy cardiogenic shock complicating cardiac surgery yields nearly 100% mortality when untreated. Use of venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock has increased worldwide recently. The aim of the current analysis was to outline the trends in use, changing patient profiles, and in-hospital outcomes including complications in patients undergoing venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. DESIGN: Analysis of extracorporeal life support organization registry from January 2010 to December 2018. SETTING: Multicenter worldwide registry. PATIENTS: Seven-thousand one-hundred eighty-five patients supported with venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. INTERVENTIONS: Venoarterial extracorporeal membrane oxygenation. MEASUREMENTS AND MAIN RESULTS: Hospital death, weaning from extracorporeal membrane oxygenation, hospital complications. Mortality predictors were assessed by multivariable logistic regression. Propensity score matching was performed for comparison of peripheral and central cannulation for extracorporeal membrane oxygenation. A significant trend toward more extracorporeal membrane oxygenation use in recent years (coefficient, 0.009; p < 0.001) was found. Mean age was 56.3 ± 14.9 years and significantly increased over time (coefficient, 0.513; p < 0.001). Most commonly, venoarterial extracorporeal membrane oxygenation was instituted after coronary artery bypass surgery (26.8%) and valvular surgery (25.6%), followed by heart transplantation (20.7%). Overall, successful extracorporeal membrane oxygenation weaning was possible in 4,520 cases (56.4%), and survival to hospital discharge was achieved in 41.7% of cases. In-hospital mortality rates remained constant over time (coefficient, -8.775; p = 0.682), whereas complication rates were significantly reduced (coefficient, -0.009; p = 0.003). Higher mortality was observed after coronary artery bypass surgery (65.4%), combined coronary artery bypass surgery with valve (68.4%), and aortic (69.6%) procedures than other indications. Lower mortality rates were observed in heart transplantation recipients (46.0%). Age (p < 0.001), central cannulation (p < 0.001), and occurrence of complications while on extracorporeal membrane oxygenation were independently associated with poorer prognosis. CONCLUSIONS: The analysis confirmed increased use of venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Mortality rates remained relatively constant over time despite a decrease in complications, in the setting of supporting older patients.

2nd Department of Medicine Department of Cardiovascular Medicine 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Czech Republic

Adult Intensive Care Services The Prince Charles Hospital Brisbane VIC Australia

Cardiac Surgery Unit ISMETT Palermo Italy

Cardiac Surgery Unit University Hospital University of Chieti Chieti Italy

Cardiothoracic Intensive Care Unit National University Hospital Singapore

Cardiovascular Research Institute Maastricht Maastricht The Netherlands

Cardiovascular Surgery and Pediatric Cardiovascular Surgery National Taiwan University Hospital Taipei Taiwan

Cardiovascular Surgery Intensive Care Unit Johns Hopkins Hospital Baltimore MD

Center for Acute Respiratory Failure and Department of Medicine Columbia University College of Physicians and Surgeons New York Presbyterian Hospital New York NY

Center for Cardiac Intensive Care Beijing Anzhen Hospital Capital Medical University Beijing People's Republic of China

Clinical Department of Cardiac Surgery Central Clinical Hospital of the Ministry of Interior and Administration Centre of Postgraduate Medical Education Warsaw Poland

Department of Cardiac Surgery University of Dusseldorf Dusseldorf Germany

Department of Cardio Thoracic Surgery Heart and Vascular Centre Maastricht University Medical Centre Maastricht The Netherlands

Department of Cardio Thoracic Surgery Massachusetts Medical Centre Boston MA

Department of Cardio Thoracic Surgery Well Cornell Medicine New York NY

Department of Cardiology Boston Children's Hospital Department of Pediatrics Harvard Medical School Boston MA

Department of Cardiothoracic Surgery Jefferson University Philadelphia PA

Department of Pathophysiology Faculty of Pharmacy Collegium Medicum Nicolaus Copernicus University Toruń Poland

Department of Pediatrics C S Mott Children's Hospital University of Michigan Ann Arbor MI

Section of Cardiac Surgery University of Michigan Ann Arbor MI

Thoracic Research Centre Collegium Medicum Nicolaus Copernicus University Innovative Medical Forum Bydgoszcz Poland

Warsaw Medical University Warsaw Poland

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025432
003      
CZ-PrNML
005      
20211026133824.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/CCM.0000000000004922 $2 doi
035    __
$a (PubMed)33729722
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kowalewski, Mariusz $u Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands $u Clinical Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior and Administration, Centre of Postgraduate Medical Education, Warsaw, Poland $u Thoracic Research Centre, Collegium Medicum, Nicolaus Copernicus University, Innovative Medical Forum, Bydgoszcz, Poland $u Warsaw Medical University, Warsaw, Poland $u Center for Acute Respiratory Failure and Department of Medicine, Columbia University College of Physicians & Surgeons/New York-Presbyterian Hospital, New York, NY $u Cardiothoracic Intensive Care Unit, National University Hospital, Singapore $u Cardiovascular Surgery Intensive Care Unit, Johns Hopkins Hospital, Baltimore, MD $u Cardiac Surgery Unit, ISMETT, Palermo, Italy $u Department of Cardiac Surgery, University of Dusseldorf, Dusseldorf, Germany $u Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, VIC, Australia $u Cardiovascular Surgery and Pediatric Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan $u Department of Cardiothoracic Surgery, Jefferson University, Philadelphia, PA $u Department of Cardio-Thoracic Surgery, Massachusetts Medical Centre, Boston, MA $u Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China $u Section of Cardiac Surgery, University of Michigan, Ann Arbor, MI $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University, Prague, and General University Hospital, Prague, Czech Republic $u Department of Pathophysiology, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Toruń, Poland $u Department of Cardiology, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA $u Department of Pediatrics, C.S. Mott Children's Hospital, University of Michigan Ann Arbor, MI $u Department of Cardio-Thoracic Surgery, Well Cornell Medicine, New York, NY $u Cardiac Surgery Unit, University Hospital, University of Chieti, Chieti, Italy $u Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands
245    10
$a Venoarterial Extracorporeal Membrane Oxygenation for Postcardiotomy Shock-Analysis of the Extracorporeal Life Support Organization Registry / $c M. Kowalewski, K. Zieliński, D. Brodie, G. MacLaren, G. Whitman, GM. Raffa, U. Boeken, K. Shekar, YS. Chen, C. Bermudez, D. D'Alessandro, X. Hou, J. Haft, J. Belohlavek, I. Dziembowska, P. Suwalski, P. Alexander, RP. Barbaro, M. Gaudino, M. Di Mauro, J. Maessen, R. Lorusso
520    9_
$a OBJECTIVES: Refractory postcardiotomy cardiogenic shock complicating cardiac surgery yields nearly 100% mortality when untreated. Use of venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock has increased worldwide recently. The aim of the current analysis was to outline the trends in use, changing patient profiles, and in-hospital outcomes including complications in patients undergoing venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. DESIGN: Analysis of extracorporeal life support organization registry from January 2010 to December 2018. SETTING: Multicenter worldwide registry. PATIENTS: Seven-thousand one-hundred eighty-five patients supported with venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. INTERVENTIONS: Venoarterial extracorporeal membrane oxygenation. MEASUREMENTS AND MAIN RESULTS: Hospital death, weaning from extracorporeal membrane oxygenation, hospital complications. Mortality predictors were assessed by multivariable logistic regression. Propensity score matching was performed for comparison of peripheral and central cannulation for extracorporeal membrane oxygenation. A significant trend toward more extracorporeal membrane oxygenation use in recent years (coefficient, 0.009; p < 0.001) was found. Mean age was 56.3 ± 14.9 years and significantly increased over time (coefficient, 0.513; p < 0.001). Most commonly, venoarterial extracorporeal membrane oxygenation was instituted after coronary artery bypass surgery (26.8%) and valvular surgery (25.6%), followed by heart transplantation (20.7%). Overall, successful extracorporeal membrane oxygenation weaning was possible in 4,520 cases (56.4%), and survival to hospital discharge was achieved in 41.7% of cases. In-hospital mortality rates remained constant over time (coefficient, -8.775; p = 0.682), whereas complication rates were significantly reduced (coefficient, -0.009; p = 0.003). Higher mortality was observed after coronary artery bypass surgery (65.4%), combined coronary artery bypass surgery with valve (68.4%), and aortic (69.6%) procedures than other indications. Lower mortality rates were observed in heart transplantation recipients (46.0%). Age (p < 0.001), central cannulation (p < 0.001), and occurrence of complications while on extracorporeal membrane oxygenation were independently associated with poorer prognosis. CONCLUSIONS: The analysis confirmed increased use of venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Mortality rates remained relatively constant over time despite a decrease in complications, in the setting of supporting older patients.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a věkové faktory $7 D000367
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a kardiochirurgické výkony $x škodlivé účinky $x mortalita $7 D006348
650    _2
$a katetrizace centrálních vén $x škodlivé účinky $x mortalita $7 D002405
650    _2
$a periferní katetrizace $x škodlivé účinky $x mortalita $7 D002406
650    _2
$a koronární bypass $x škodlivé účinky $x mortalita $7 D001026
650    _2
$a mimotělní membránová oxygenace $x škodlivé účinky $x mortalita $x statistika a číselné údaje $x trendy $7 D015199
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a transplantace srdce $x škodlivé účinky $x mortalita $7 D016027
650    _2
$a chirurgická náhrada chlopně $x škodlivé účinky $x mortalita $7 D019918
650    _2
$a mortalita v nemocnicích $7 D017052
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a registrace $7 D012042
650    _2
$a kardiogenní šok $x etiologie $x terapie $7 D012770
650    _2
$a míra přežití $7 D015996
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zieliński, Kamil $u Warsaw Medical University, Warsaw, Poland
700    1_
$a Brodie, Daniel $u Center for Acute Respiratory Failure and Department of Medicine, Columbia University College of Physicians & Surgeons/New York-Presbyterian Hospital, New York, NY
700    1_
$a MacLaren, Graeme $u Cardiothoracic Intensive Care Unit, National University Hospital, Singapore
700    1_
$a Whitman, Glenn $u Cardiovascular Surgery Intensive Care Unit, Johns Hopkins Hospital, Baltimore, MD
700    1_
$a Raffa, Giuseppe M $u Cardiac Surgery Unit, ISMETT, Palermo, Italy
700    1_
$a Boeken, Udo $u Department of Cardiac Surgery, University of Dusseldorf, Dusseldorf, Germany
700    1_
$a Shekar, Kiran $u Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, VIC, Australia
700    1_
$a Chen, Yih-Sharng $u Cardiovascular Surgery and Pediatric Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan
700    1_
$a Bermudez, Christian $u Department of Cardiothoracic Surgery, Jefferson University, Philadelphia, PA
700    1_
$a D'Alessandro, David $u Department of Cardio-Thoracic Surgery, Massachusetts Medical Centre, Boston, MA
700    1_
$a Hou, Xiaotong $u Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China
700    1_
$a Haft, Jonathan $u Section of Cardiac Surgery, University of Michigan, Ann Arbor, MI
700    1_
$a Belohlavek, Jan $u 2nd Department of Medicine-Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University, Prague, and General University Hospital, Prague, Czech Republic
700    1_
$a Dziembowska, Inga $u Department of Pathophysiology, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Toruń, Poland
700    1_
$a Suwalski, Piotr $u Clinical Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior and Administration, Centre of Postgraduate Medical Education, Warsaw, Poland
700    1_
$a Alexander, Peta $u Department of Cardiology, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA
700    1_
$a Barbaro, Ryan P $u Department of Pediatrics, C.S. Mott Children's Hospital, University of Michigan Ann Arbor, MI
700    1_
$a Gaudino, Mario $u Department of Cardio-Thoracic Surgery, Well Cornell Medicine, New York, NY
700    1_
$a Di Mauro, Michele $u Cardiac Surgery Unit, University Hospital, University of Chieti, Chieti, Italy
700    1_
$a Maessen, Jos $u Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands $u Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands
700    1_
$a Lorusso, Roberto $u Department of Cardio-Thoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands $u Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands
773    0_
$w MED00009514 $t Critical care medicine $x 1530-0293 $g Roč. 49, č. 7 (2021), s. 1107-1117
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33729722 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133830 $b ABA008
999    __
$a ok $b bmc $g 1714469 $s 1145939
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 49 $c 7 $d 1107-1117 $e 20210701 $i 1530-0293 $m Critical care medicine $n Crit Care Med $x MED00009514
GRA    __
$a K12 HL138039 $p NHLBI NIH HHS $2 United States
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...